Sec. 9. Mortality reporting
551 words·~3 min read·
/bill/113/hr/672/ih/section-9A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part A of title V of the Public Health Service Act ( 42 U.S.C. 290aa et seq. ), as amended by section 7, is further amended by adding at the end the following: Not later than July 1, 2014, the Secretary, acting through the Administrator, shall require that a Model Opioid Treatment Program Mortality Report be completed and submitted to the Administrator for each individual who dies while receiving treatment in an opioid treatment program. As a condition for receiving funds under section 399O, each State shall require that any individual who signs a death certificate where an opioid drug is detected in the body of the deceased, or where such drug is otherwise associated with the death, report such death to the Administrator by submitting a Model Opioid Treatment Program Mortality Report described in paragraph (3).
Such report shall be submitted to the Administrator on or before the later of— 90 days after the date of signing the death certificate; or as soon as practicable after the date on which the necessary postmortem and toxicology reports become available to such individual, as required by the Secretary. The Administrator, in consultation with State and local medical examiners, prescribing physicians, hospitals, and any other organization that the Administrator determines appropriate, shall develop a Model Opioid Treatment Program Mortality Report to be used under paragraphs
(1)and (2). Not later than July 1, 2014, the Administrator shall establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry (referred to in this subsection as the Registry ) to track opioid-related deaths and information related to such deaths. In establishing the uniform reporting criteria for the Registry, the Director of the Centers for Disease Control and Prevention shall consult with the Administrator, State and local medical examiners, prescribing physicians, hospitals, and any other organization that the Director determines is appropriate for purposes of this subsection. The registry shall be designed as a uniform reporting system for opioid-related deaths and shall require the reporting of information with respect to such deaths, including— the particular drug formulation used at the time of death; the dosage level; a description of the circumstances surrounding the death in relation to the recommended dosage involved; a disclosure of whether the medication involved can be traced back to a physician’s prescription; a disclosure of whether the individual was in an opioid treatment program at the time of death; the age and sex of the individual; and other non-personal information such as that included in filed National Association of Medical Examiners Pediatric Toxicology Registry case reports as required under the privacy standard for the de-identification of health information pursuant to the regulations contained in part 164 of title 45, Code of Federal Regulations. There is authorized to be appropriated $5,000,000 for each of fiscal years 2014 through 2018 to carry out this subsection. Not later than the January 1 of the first fiscal year beginning 2 years after the date of enactment of this section, and each January 1 thereafter, the Director of the Centers for Disease Control and Prevention shall submit to the Secretary a report, based on information contained in the Registry described in subsection (b), concerning the number of methadone-related deaths in the United States for the year for which the report is submitted. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 9
Mortality reporting
Cites 1Cited by 0 across 0 sources